MedTrace Logo

A Study of Paravertebral Block in Thoracic Outlet Syndrome

NCT05544721 · Status: ENROLLING_BY_INVITATION · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-11-14

No results posted yet for this study

Summary

This research is being done to evaluate the effects of receiving only a paravertebral block prior to first rib resection procedure versus receiving the block both pre and post procedure.

Conditions

  • Thoracic Outlet Syndrome

Interventions

DRUG

Ropivacaine

0.5% 3-4 mL per level, with levels T1 and T2 will be used as the block injectate

Sponsors & Collaborators

Principal Investigators

  • Houssam Farres, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-05
Primary Completion
2027-08-31
Completion
2027-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05544721 on ClinicalTrials.gov